Cell growth inhibitor and screening method thereof
AssigneeThe University of Tokyo
InventorsSatoshi Inoue, Kenichi Takayama
Life of this patent
Estimating the term…
Abstract
An object is to provide a cell growth inhibitor also effective for androgen-independent prostate cancer. The present invention provides a cell growth inhibitor having, as an active ingredient, an expression inhibitor or function inhibitor of an antisense RNA (CTBP1-AS) expressed in the vicinity of an androgen receptor (AR) binding site of a C-terminal binding protein (CTBP1) gene.
Claims10
A cell growth inhibitor
- comprising a CTBP1-AS (C-terminal binding protein 1-antisense) expression inhibitor or function inhibitor as an active ingredient, wherein
- the CTBP1-AS expression inhibitor or function inhibitor is a double-stranded RNA having an RNAi effect against CTBP1-AS and
- one strand of the double-stranded RNA comprises a base sequence complementary to the base sequence of any of SEQ ID NO:3 to 6 and 24 to 52.
A method of screening growth inhibitors of cells in which CTBP1-AS has been expressed, comprising:
- bringing cells in which CTBP1-AS has been expressed or a cell extract thereof into contact with test compounds in the presence of androgen;
- measuring an expression level of CTBP1-AS;
- and
- selecting, from the test compounds, test compounds decreasing the expression level of CTBP1-AS compared with an expression level measured in the absence of the test compounds.
A method of screening proliferation inhibitors of cells in which CTBP1-AS has been expressed, comprising:
- bringing cells in which a CTBP1 gene has been expressed or a cell extract thereof into contact with test compounds in the presence of androgen;
- measuring an expression level of the CTBP1 gene;
- and
- selecting, from the test compounds, test compounds increasing the expression level of the CTBP1 gene compared with an expression level measured in the absence of the test compounds.
Dependencies are inferred from the claim text.